Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

BACKGROUND: Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differentiation antigens. CCS is poorly sensitive to chemotherapy. Multi-kinase inhibitor...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Tazzari, Marcella, Palassini, Elena, Vergani, Barbara, Villa, Antonello, Rini, Francesca, Negri, Tiziana, Colombo, Chiara, Crippa, Flavio, Morosi, Carlo, Casali, Paolo G, Pilotti, Silvana, Stacchiotti, Silvia, Rivoltini, Licia, Castelli, Chiara
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342079/
https://ncbi.nlm.nih.gov/pubmed/25880253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1044-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items